Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group.
Kunanya SuwannayingChalinee MonsereenusornPiya RujkijyanontPiti TechavichitKamon PhuakpetPongpak PongphitchaSu-On ChainansamitThirachit ChotsampancharoenAngkana WinaichatsakChanchai TraivareeLalita SathitsamitphongSomjai KanjanapongkulPatcharee KomvilaisakKleebsabai SanpakitApichat PhotiaPanya SeksarnSurapon WiangnonSuradej Hongengnull nullPublished in: Pediatric blood & cancer (2022)
A combination of HSCT and cis-RA successfully improved the outcomes of patients with HR-NBL in immunotherapy inaccessible settings.